drugset / Trial / NCT01956786

Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

NCT01956786 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the efficacy of Amlodipine-Folic Acid Tablets on reduction of blood pressure and plasma total homocysteine.

Timeline

Start
2013-09
Primary completion
2013-12
Completion
2014-02

Outcome

Met primary endpoint

paper B group also had a higher rate of lowering both tHcy and BP (20.3% vs. 6.0%; OR: 5.90; 95% CI, 2.11-16.47, P < .001). PMID 37433173 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg —
Subject folic acid Other / unclassified 0.4 mg —
Subject folic acid Other / unclassified 0.8 mg —